PDB33 THE EFFICACY OF INSULIN GLARGINE COMPARED TO OTHER INJECTABLE THERAPIES-A META-ANALYSIS OF CLINICAL OUTCOMES IN INSULIN NAÏVE TYPE 2 DIABETES PATIENTS

K Pascoe; CM McDonald-Everett; P FitzGerald; NR Yurgin; K Secnik

doi:10.1016/s1098-3015(10)63303-7

PDB33 THE EFFICACY OF INSULIN GLARGINE COMPARED TO OTHER INJECTABLE THERAPIES-A META-ANALYSIS OF CLINICAL OUTCOMES IN INSULIN NAÏVE TYPE 2 DIABETES PATIENTS

Value in Health ◽

10.1016/s1098-3015(10)63303-7 ◽

2006 ◽

Vol 9 (6) ◽

pp. A234

Author(s):

K Pascoe ◽

CM McDonald-Everett ◽

P FitzGerald ◽

NR Yurgin ◽

K Secnik

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Meta Analysis ◽

Diabetes Patients

Download Full-text

Modeling the lifetime costs of insulin glargine and insulin detemir in type 1 and type 2 diabetes patients in Canada: a meta-analysis and a cost-minimization analysis

Journal of Medical Economics ◽

10.3111/13696998.2011.561390 ◽

2011 ◽

Vol 14 (2) ◽

pp. 207-216 ◽

Cited By ~ 10

Author(s):

Anne-Laure Guillermin ◽

Yevgeniy Samyshkin ◽

Donna Wright ◽

Tini Nguyen ◽

Julie Villeneuve

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Detemir ◽

Cost Minimization ◽

Meta Analysis ◽

Cost Minimization Analysis ◽

Lifetime Costs ◽

Diabetes Patients

Download Full-text

Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching From Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+ Subgroup Analyses

Diabetes ◽

10.2337/db18-1057-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1057-P

Author(s):

SEAN D. SULLIVAN ◽

TIMOTHY S. BAILEY ◽

RONAN ROUSSEL ◽

FANG L. ZHOU ◽

ZSOLT BOSNYAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Real World ◽

Insulin Detemir ◽

Insulin Degludec ◽

Subgroup Analyses

Download Full-text

Glucagon-like peptide-1 mimetics, optimal for Asian type 2 diabetes patients with and without overweight/obesity: meta-analysis of randomized controlled trials

Scientific Reports ◽

10.1038/s41598-017-16018-9 ◽

2017 ◽

Vol 7 (1) ◽

Cited By ~ 4

Author(s):

Fang Zhang ◽

Lizhi Tang ◽

Yuwei Zhang ◽

Qingguo Lü ◽

Nanwei Tong

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Diabetes Patients

Download Full-text

Comparison between insulin degludec/liraglutide treatment and insulin glargine/lixisenatide treatment in type 2 diabetes: a systematic review and meta-analysis

Expert Opinion on Pharmacotherapy ◽

10.1080/14656566.2017.1400011 ◽

2017 ◽

Vol 18 (17) ◽

pp. 1789-1798 ◽

Cited By ~ 14

Author(s):

Xiaoling Cai ◽

Xueying Gao ◽

Wenjia Yang ◽

Linong Ji

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Insulin Glargine ◽

Meta Analysis ◽

Insulin Degludec

Download Full-text

Meta-analysis of the insulin dosage in Chinese type 2 diabetes patients receiving insulin treatment

Diabetes Research and Clinical Practice ◽

10.1016/s0168-8227(16)31453-x ◽

2016 ◽

Vol 120 ◽

pp. S196

Author(s):

Xiaoling Cai ◽

Wenjia Yang ◽

Xueying Gao ◽

Lingli Zhou ◽

Xueyao Han ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Treatment ◽

Meta Analysis ◽

Insulin Dosage ◽

Diabetes Patients

Download Full-text

Quality of life, health status and clinical outcomes in Type 2 diabetes patients

Quality of Life Research ◽

10.1007/s11136-006-9105-0 ◽

2006 ◽

Vol 16 (2) ◽

pp. 165-177 ◽

Cited By ~ 88

Author(s):

Murali Sundaram ◽

Jan Kavookjian ◽

Julie Hicks Patrick ◽

Lesley-Ann Miller ◽

S. Suresh Madhavan ◽

...

Keyword(s):

Quality Of Life ◽

Type 2 Diabetes ◽

Health Status ◽

Clinical Outcomes ◽

Diabetes Patients

Download Full-text

PCN11 Decreased Risk of Prostate Cancer in Type 2 Diabetes Patients: A Meta-Analysis of Cohort Studies

Value in Health ◽

10.1016/j.jval.2012.08.309 ◽

2012 ◽

Vol 15 (7) ◽

pp. A655

Author(s):

B. Dipika ◽

K. Gudala ◽

K. Undela ◽

T. Pramil ◽

A. Bhansali

Keyword(s):

Prostate Cancer ◽

Type 2 Diabetes ◽

Cohort Studies ◽

Meta Analysis ◽

Diabetes Patients

Download Full-text

Treatment Satisfaction with Insulin Glargine in Insulin-Naïve Type 2 Diabetes Patients—A Hong Kong Based Registry

Journal of Diabetes Mellitus ◽

10.4236/jdm.2014.43033 ◽

2014 ◽

Vol 04 (03) ◽

pp. 232-241

Author(s):

Wing-Bun Chan ◽

Wilson W. M. Ngai ◽

Peter Chun-Yip Tong

Keyword(s):

Type 2 Diabetes ◽

Hong Kong ◽

Insulin Glargine ◽

Treatment Satisfaction ◽

Diabetes Patients

Download Full-text

PDB32 EVALUATING THE LONG-TERM CLINICAL AND ECONOMIC IMPLICATIONS OF CONVERTING TYPE 2 DIABETES PATIENTS TO INSULIN DETEMIR (±ORAL HYPOGLYCEMIC AGENTS) FROM INSULIN GLARGINE BASED REGIMENS IN GERMANY; DATA FROMTHE PREDICTIVE STUDY

Value in Health ◽

10.1016/s1098-3015(10)64980-7 ◽

2007 ◽

Vol 10 (6) ◽

pp. A263-A264

Author(s):

WJ Valentine ◽

G Goodall ◽

M Aagren ◽

S Nielsen ◽

R Kotchie

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Detemir ◽

Hypoglycemic Agents ◽

Oral Hypoglycemic Agents ◽

Economic Implications ◽

Predictive Study ◽

Diabetes Patients

Download Full-text

Plasma levels of von Willebrand factor in type 2 diabetes patients with and without cardiovascular diseases: A meta‐analysis

Diabetes/Metabolism Research and Reviews ◽

10.1002/dmrr.3193 ◽

2019 ◽

Vol 36 (1) ◽

Cited By ~ 3

Author(s):

Xun Peng ◽

Xia Wang ◽

Mengge Fan ◽

Junyu Zhao ◽

Liao Lin ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Diseases ◽

Von Willebrand Factor ◽

Plasma Levels ◽

Meta Analysis ◽

Von Willebrand ◽

Willebrand Factor ◽

Diabetes Patients

Download Full-text